Israeli computer-aided detection (CAD) developer Rcadia Medical Imaging has received a second U.S. Food and Drug Administration (FDA) clearance for its COR Analyzer family of products.
The new clearance includes segmentation of the coronary artery tree with no human intervention and automatic detection of pathologies in the main coronary arteries, according to the Haifa-based firm. COR Analyzer is designed to assist in triaging patients for coronary artery disease, Rcadia said.
By AuntMinnie.com staff writers
September 26, 2007
Related Reading
Rcadia receives FDA OK, February 14, 2007
Copyright © 2007 AuntMinnie.com
